Cargando…
Galectin 3 for the diagnosis of bladder cancer
OBJECTIVE: To evaluate serum levels of galectin-3 (G-3) in patients with bladder cancer and a control group, as a potential diagnostic and prognostic serum tumour marker. PATIENTS AND METHODS: Between November 2012 and January 2013, 55 patients (median age 58 years) were enrolled into three groups,...
Autores principales: | El Gendy, Hoda, Madkour, Bothina, Abdelaty, Sara, Essawy, Fayza, Khattab, Dina, Hammam, Olfat, El Kholy, Amr, Nour, Hani H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434779/ https://www.ncbi.nlm.nih.gov/pubmed/26019945 http://dx.doi.org/10.1016/j.aju.2013.10.004 |
Ejemplares similares
-
The expression of p63 in bladder cancer vs. chronic bilharzial bladder
por: Mursi, Khaled, et al.
Publicado: (2013) -
Human epidermal growth factor receptor 2 (HER2) and the future of bladder carcinoma
por: Sarkis, Julien, et al.
Publicado: (2020) -
Human epidermal growth factor receptor 2 (HER2) gene amplification in non-muscle invasive urothelial bladder cancers: Identification of patients for targeted therapy
por: Agrawal, Vinita, et al.
Publicado: (2020) -
Gene expression analysis and the risk of relapse in favorable histology Wilms’ tumor
por: Abdel-Monem, Mariam M., et al.
Publicado: (2022) -
Drug-delivering devices in the urinary tract: A systematic review
por: Kallidonis, Panagiotis, et al.
Publicado: (2021)